Fresh analysis suggests that individuals who come off popular slimming jabs like semaglutide or tirzepatide tend to recover lost weight much more quickly than those who halt conventional lifestyle regimens.
Research printed in a major medical journal points out that while overweight people can lose about a fifth of their total mass while undergoing treatment, the mass is regained at an estimated rate of 0.8 kg per month once they quit.
"Individuals purchasing these drugs need to be aware of the risk of fast weight regain when the medication concludes," warns researcher Dr. Susan Jebb.
That rate of recovery suggests a return to pre-treatment weight in about one and a half years.
Comparing Treatments
The research, which examined dozens of trials involving over 9,000 of participants, compared the effects of the injectable medications with other pills.
The team emphasize that individuals who lose weight through lifestyle changes alone typically experience a more gradual creep back—perhaps 100 grams monthly—post-intervention.
Understanding the Fast Rebound
Experts propose the mechanism of the injections is key to understanding the heightened regain.
GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Long-term administration of GLP-1 levels far above than the body's typical production may cause the body to generate a reduced amount of its own natural GLP-1, and could diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.
"Stopping of this hormone supplement results in hunger is no longer kept in check, making overeating much more probable."
A Chronic Issue?
Health authorities advise the injections for people with obesity-related medical conditions, alongside recommended lifestyle changes.
Many experts contend that, considering the high risk of weight regain, the treatment might need to be long-term.
This view is reinforced by pharmaceutical companies, who note that the findings "highlight the chronic character of obesity," similar to managing conditions like hypertension.
User Testimonies
Users who have stopped the jabs report a intense resurgence of cravings.
"It felt as if a switch flipping and you're instantly ravenous," said one woman.
The struggle is worsened if patients have not adopted lasting lifestyle or habit modifications during therapy.
Significant Use
Figures show that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with desire remaining high.
- Use is more common among women compared to men.
- The middle-aged demographic shows the greatest usage rates.
- Many obtain the medications through private healthcare rather than public health services.
In conclusion, clinicians stress that while GLP-1 drugs are effective agents for weight loss, they are not a magic cure and lasting health benefits relies on combined behavioural support.
